(QLTI) The 2023 Series Trust II - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • • Foreign Large Value
QLTI: Non-U.S. Equities, High-Quality Stocks, Foreign Large Value
The fund is an actively managed exchange-traded fund ('ETF') that seeks to achieve its investment objective by investing primarily in non-U.S. equities that the fund's adviser, Grantham, Mayo, Van Otterloo & Co. LLC ('GMO' or the 'Adviser'), believes to be of high quality. It may invest in the GMO U.S. Treasury Fund, a mutual fund advised by GMO, or in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds. It is non-diversified.
Additional Sources for QLTI ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
QLTI ETF Overview
| Market Cap in USD | 17m |
| Category | Foreign Large Value |
| IPO / Inception | 2024-10-28 |
QLTI ETF Ratings
| Growth 5y | 9.41% |
| Fundamental | - |
| Dividend | 7.16% |
| Rel. Strength Industry | -0.95 |
| Analysts | - |
| Fair Price Momentum | 22.93 USD |
| Fair Price DCF | - |
QLTI Dividends
| Dividend Yield 12m | 0.18% |
| Yield on Cost 5y | 0.17% |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 100.0% |
QLTI Growth Ratios
| Growth Correlation 3m | 71.3% |
| Growth Correlation 12m | 33.7% |
| Growth Correlation 5y | 33.7% |
| CAGR 5y | 0.94% |
| CAGR/Max DD 5y | 0.11 |
| Sharpe Ratio 12m | -0.28 |
| Alpha | -5.58 |
| Beta | 0.25 |
| Volatility | 13.91% |
| Current Volume | 82.6k |
| Average Volume 20d | 4.7k |
What is the price of QLTI stocks?
As of March 09, 2025, the stock is trading at USD 25.10 with a total of 82,595 shares traded.
Over the past week, the price has changed by +3.13%, over one month by +4.66%, over three months by +3.67% and over the past year by +0.94%.
As of March 09, 2025, the stock is trading at USD 25.10 with a total of 82,595 shares traded.
Over the past week, the price has changed by +3.13%, over one month by +4.66%, over three months by +3.67% and over the past year by +0.94%.
Is The 2023 Series Trust II a good stock to buy?
Neither. Based on ValueRay Analyses, The 2023 Series Trust II is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 9.41 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of QLTI as of March 2025 is 22.93. This means that QLTI is currently overvalued and has a potential downside of -8.65%.
Neither. Based on ValueRay Analyses, The 2023 Series Trust II is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 9.41 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of QLTI as of March 2025 is 22.93. This means that QLTI is currently overvalued and has a potential downside of -8.65%.
Is QLTI a buy, sell or hold?
The 2023 Series Trust II has no consensus analysts rating.
The 2023 Series Trust II has no consensus analysts rating.
What are the forecast for QLTI stock price target?
According to ValueRays Forecast Model, QLTI The 2023 Series Trust II will be worth about 25.2 in March 2026. The stock is currently trading at 25.10. This means that the stock has a potential upside of +0.24%.
According to ValueRays Forecast Model, QLTI The 2023 Series Trust II will be worth about 25.2 in March 2026. The stock is currently trading at 25.10. This means that the stock has a potential upside of +0.24%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 25.2 | 0.2% |